Reasons for complementary therapies and characteristics of users among HIV-infected people

International Journal of STD and AIDS

Volumn 14, Issue 7, 2003, Pages 482-486

  Agnoletto, Vittorio ^a   Chiaffarino, Francesca ^a   Nasta, Paola ^a   Rossi, Roberto ^a   Parazzini, Fabio ^a  

^a LILA   (Italy)

Author keywords

Complementary and alternative therapy; HIV infected subject

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUPUNCTURE; ADOLESCENT; ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; CHILD; DIET SUPPLEMENTATION; ENERGY; EUROPE; FATIGUE; FEMALE; GASTROINTESTINAL SYMPTOM; HEALTH CARE ORGANIZATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMEOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; LIPODYSTROPHY; MAJOR CLINICAL STUDY; MALAISE; MALE; NEUROPATHY; NUTRITIONAL SUPPORT; PHYTOTHERAPY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; PSYCHOTHERAPY; QUESTIONNAIRE; SIDE EFFECT; SKIN DISEASE;

ADULT; AGE FACTORS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMPLEMENTARY THERAPIES; EDUCATIONAL STATUS; FEMALE; GASTROINTESTINAL DISEASES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM DISEASES; QUESTIONNAIRES; SEX FACTORS;

EID: 0038344020     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203322025803     Document Type: Article

References (11)

1. Ernst E. Complementary AIDS therapies: the good, the bad and the ugly. Int J STD AIDS 1997;8:281-5
2. Fairfield KM, Eisenberg DM, Davis RB, et al. Pattern of use, expenditures and perceived efficacy of complementary and alternative therapies in HIV-infected patients. Arch Intern Med 1998;158:2257-64
3. Ostrow MJ, Cornelisse PGA, Heath KV, et al. Determinants of complementary therapy use in HIV-infected individuals receiving antiretroviral or anti-opportunistic agents. J Acquir Immune Defic Syndr Hum Retrovir 1997;15:115-20
4. Anderson W, Bonnie BO, MacGregor RR, et al. Patient use and assessment of conventional and alternative therapies for HIV infection and AIDS. AIDS 1993;7:561-6
5. de Visser R, Ezzy D, Bartos M. Alternative or complementary? Nonallopathic therapies for HIV/AIDS. Altern Ther Health Med 2000;6:44-52
6. Agnoletto V, Martini M, Hollander L, et al. ELECTHIV: European Level Evaluation of Complementary Techniques in HIV. [abs 568] 7th European Conference on Clinical Aspects and treatment of HIV infection, Lisbon, October 23-27, 1999
7. Brewslow NE, Day NE. Statistical methods in cancer research. Lyon: IARC Scientific Publication 32, Vol. 1, 1980
8. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. February 4, 2002. Department of Health and Human Services (DHHS) and the Henry J Kaiser Family Foundation. [http://www.hivatis.org]
9. Langewitz W, Ruttiman S, Laifer G, Maurer P, Kiss A. The integration of alternative treatment modalities in HIV infection: the patient's perspective. J Psychosom Res 1994;38:687-93
10. James JS. St John's wort warning: do not combine with protease inhibitors, NNRTIs. AIDS Treatment News 2000;337:3-5
11. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet 2000;355:547-8